Sertraline
SSRI • Last reviewed 2025-09-23
Brands: Zoloft
Sources updated 2025 • 1 references
General Information
Indicated for: Sertraline hydrochloride tablets are a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of ( 1 ): • Major depressive disorder (MDD) • Obsessive-compulsive disorder (OCD) • Panic disorder (PD) • Posttraumatic stress disorder (PTSD) • Social anxiety disorder (SAD) • Premenstrual dysphoric disorder (PMDD) SSRI
Dosage & Administration
Typical dose range: 50–200 mg/day
Indications (label)
Sertraline hydrochloride tablets are a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of ( 1 ): • Major depressive disorder (MDD) • Obsessive-compulsive disorder (OCD) • Panic disorder (PD) • Posttraumatic stress disorder (PTSD) • Social anxiety disorder (SAD) • Premenstrual dysphoric disorder (PMDD)
Mechanism (brief)
Selective serotonin reuptake inhibitor (SSRI).
Metabolism & Half‑life
- Metabolism: Multiple CYPs; fewer DDIs relative to fluoxetine/paroxetine.
- Half‑life: ~26 h.
Therapeutic Drug Monitoring (TDM)
Recommended: No
References
- Sertraline labelExact (2025)